What is Low-Level Laser Therapy (LLLT)?
LLLT, also known as photobiomodulation (PBM), is a non-invasive treatment that uses low-intensity lasers or light-emitting diodes (LEDs) to stimulate cellular activity. It works by delivering specific wavelengths of light to targeted tissues, promoting cellular repair, reducing inflammation, and alleviating pain. Unlike high-intensity lasers used for surgical procedures, LLLT does not produce heat or damage tissue, making it a safe and effective option for chronic pain management.
Key Findings from the 2003 Systematic Review
Bjordal et al. (2003) conducted a comprehensive analysis of 88 randomised controlled trials, with 20 meeting their strict inclusion criteria. Their findings revealed that:
-
LLLT significantly reduces pain intensity in patients with chronic joint disorders.
-
Location-specific dosing—applying LLLT directly to the affected joint capsule—yielded better outcomes than generalised application.
-
Patients experienced improved overall health status alongside pain relief, suggesting broader benefits beyond just pain reduction.
-
The review emphasised the need for standardised treatment protocols to enhance consistency and effectiveness in clinical applications.
-
After excluding trials that did not irradiate the joint capsule or used doses outside the effective range, 11 RCTs involving 565 patients were deemed methodologically sound, with an average PEDro score of 6.9 (on a scale where higher scores indicate better quality).
-
The key findings from these 11 trials indicated that LLLT, when applied within the suggested dose range directly to the knee, temporomandibular, or zygapophyseal joints, resulted in a mean weighted pain reduction of 29.8 mm on a 100 mm visual analogue scale (VAS), with a 95% confidence interval ranging from 18.9 to 40.7 mm, favoring the active LLLT groups.
-
This significant reduction in pain underscores the potential of LLLT as an effective treatment modality for chronic joint pain when administered with appropriate dosing and precise application to the affected joint capsules.
Why LLLT is Effective for Chronic Joint Disorders
LLLT works by penetrating deep into tissues and stimulating mitochondrial function. This process leads to:
-
Increased ATP production, fueling cellular repair and regeneration.
-
Enhanced blood circulation, improving nutrient and oxygen delivery to affected areas.
-
Reduction in inflammation and oxidative stress, which are key contributors to chronic joint pain.
-
Neuromodulation effects, helping to decrease pain perception and improve joint mobility.
Clinical Applications and Future Research
The review underscores the importance of precise dosing and treatment protocols to optimise LLLT outcomes. While the evidence strongly supports its pain-relieving properties, the authors call for further research to standardise application methods and confirm long-term benefits.
At REDi, we prioritise science-backed recovery solutions to enhance performance, reduce pain, and accelerate healing. Our advanced red light therapy devices leverage the latest in photobiomodulation technology, offering clinically validated benefits for athletes, individuals recovering from injuries, and those suffering from chronic pain conditions.
Conclusion
Bjordal et al.'s (2003) systematic review highlights the growing credibility of LLLT as a non-invasive, drug-free solution for managing chronic joint pain. With ongoing advancements in light therapy, the future holds great potential for enhancing mobility, reducing discomfort, and improving quality of life for those with chronic joint disorders.
Reference: Bjordal, J. M., Couppé, C., Chow, R. T., Tunér, J., & Ljunggren, E. A. (2003). A systematic review of low-level laser therapy with location-specific doses for pain from chronic joint disorders. The Australian Journal of Physiotherapy, 49(2), 107–116. https://doi.org/10.1016/s0004-9514(14)6